The Anal Pap:
A guide for primary care providers
BIBLIOGRAPHY

[1]Palefsky JM, Cranston RD.  Anal squamous intraepithelial lesions (ASIL): Diagnosis, screening and treatment.  UpToDate, online version 9.2.

[2]Daling JR, Weiss NS, Hislop TG, et al.  Sexual practices, sexually transmitted disease, and the incidence of anal cancer.  N Engl J Med 1987; 317: 973-7.

[3]Palefsky JM, Holly EA, Hogeboom CJ, et al.  Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.  J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 314-319.

[4] Palefsky JM, Cranston RD.  Virology of human papillomavirus infections and the link to cancer.   UpToDate, online version 9.2.

[5] Vernon SD, Hart CE, Reeves WC, Icenogle JP.  The HIV-1 tat protein enhances E-2 dependent human papillomavirus 16 transcription.  Virus Res 1993; 27:133.

[6]Palefsky JM, Berry JM.  Pathogenesis and clinical manifestations of HIV-associated anogenital neoplasia.  Web Site: The AIDS Knowledge Base.  November 1998.

[7] Palefsky JM, Holly EA, Ralston ML, et al.  High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative  homosexual and bisexual men.  AIDS 1998; 12:495-503.

[8] Frisch M, Bengt G, et al.  Sexually transmitted infection as cause of anal cancer.  N Engl J Med 1997; 337:19:1350-1358. 

[9] Holly EA, Ralston ML, Darragh TM et al.  Prevalence and risk factors for anal squamous intraepithelial lesions in women.  Journal of Nat Cancer Inst 2001:93:11:843-849.

[10]Friis S, Kjaer SK, Frisch M et al.  Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for Condyloma Acuminata.  Journal Infect Disease  1997; 175:743-8.

[11]Ryan DP, Compton CC, Mayer RJ.  Carcinoma of the anal canal.  N Engl J Med 2000; 342:11:792-800.

[12]Penn, I. Cancer of the anogenital region in renal transplant recipients.  Cancer 1986; 58: 611-616.

[13]Martins, CR.  HPV-induced anal dysplasia:  What do we know and what can we do about it? The Hopkins HIV Report.  May 2001.

[14]Darragh TM, Jay N, et al.  Comparison of conventional cytologic smears and ThinPrep preparations from the anal canal.  Acta Cytologica 1997; 41:4:1167-1170.

[15]Palefsky JM, Holly EA, Hogeboom CJ, et al.  Anal cytology as a screening tool for anal squamous intraepithelial lesions.  J Acquir Immune Defic Syndr Hum Retrovirol  1997: 14: 415-422.

[16]Goldie SJ, Kuntz KM, Weinstein MC, et al.  The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.  JAMA 1999: 281: 1822-1829.

[17]Goldie SJ, Kuntz KM, Weinstein MC, et al. The cost-effectiveness of screening for anal squamous intraepithelial lesions in HIV-negative homosexual and bisexual men.  Am J Med 2000; 108:634-641.
CONTENTS:
Introduction
Histopathology
How to perform an anal pap
Treatment
Epidemiology
Cost-effectiveness
Who and how often to screen
Anal pap at a glance
Links
Anal pap: does it qualify to be a screening test?
Bibliography
Basic Science of HPV
The Anal Pap:
A guide for primary care providers
Demetre Daskalakis, MD

Back to Consumer
Council